News

The Psychiatry Residency Training program at the University of Pittsburgh is reputed for its clinical and research excellence and is consistently ranked high in the Doximity poll. In 2015 it was ranked seventh overall. The program receives more than 1300 applications per year, and 17 residents are accepted into the program annually. The diversity of the cohorts makes it difficult to describe the typical resident...

Institute of Living to Present David Brent, MD with the C. Charles Burlingame AwardFor his multiple important contributions to psychiatry throughout his distinguished career, David Brent, MD was selected by the Institute of Living/Hartford Hospital to receive the C. Charles Burlingame Award.The Burlingame Award will formally be presented to Dr. Brent at a special reception on evening of October 21st and he will...

Effect of a Cognitive-Behavioral Prevention Program on Depression 6 Years after Implementation among At-Risk Adolescents: A Randomized Clinical Trial Brent DA, Brunwasser SM, Hollon SD, Weersing VR, Clarke GN, JF Dickerson, Beardslee WR, Gladstone TRG, Porta G, Lynch FL, Iyengar S and Garber J JAMA Psychiatry. Published online September 30, 2015 Adolescents whose parents have a history of depression are at risk for...

Heather Joseph, DO Selected by AACAP to Participate in Educational Outreach ProgramThe American Academy of Child and Adolescent Psychiatry (AACAP) has selected Dr. Heather Joseph as a travel award recipient through the Academy?s Educational Outreach Program for Child and Adolescent Psychiatry Residents. This is the second time that Dr. Joseph has been selected to participate in this highly competitive program; she...

Dysregulated ErbB4 Splicing in Schizophrenia: Selective Effects on Parvalbumin ExpressionChung DW, Volk DW, Arion D, Zhang Y, Sampson AR and Lewis DAAmerican Journal of Psychiatry, Published online September 2015In a study recently published online in the American Journal of Psychiatry, investigators in the Department of Psychiatry?s Translational Neuroscience Program investigated whether dysregulated ErbB4...

Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: A randomized placebo-controlled trialLenze EJ, Mulsant BH, Blumberger DM, Karp JF, Newcomer JW, Anderson SJ, Dew MA, Butters MA, Stack JA, Begley AE and Reynolds CFThe Lancet, 2015; 386(10011):2404-2412.Treatment-resistant major depressive disorder is common and potentially life...